Categories
In the News Latest News Marketing

Earth Science Tech, Inc. (ETST) Announces Cancellation of 18,000,000 Common and 5,200,000 Preferred Shares, Updating the Outstanding Shares to 36,384,394 from 53,902,354

 Earth Science Tech Inc. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces it has canceled 18,000,000 common shares along with 5,200,000 Series A Preferred shares through a confidential settlement with Majorca LTD, the majority shareholder. The Company now has zero preferred shares outstanding and 36,384,394 common shares outstanding which is down from 53,902,354.

ETST’s President, Director and Chairman Nickolas S. Tabraue stated, “We are extremely pleased to have reached a settlement with Majorca, LTD and the value it adds for our shareholders is immediately recognized and meaningful.”

Categories
Cannabinoids Cannabis Events Cannabis Oils Feature Story Marketing Science Uncategorized

A Guide to Cannabinoids – The Science, The Synergy and its Role in Society

People today are more eager than ever to take a more active role in their overall health and wellness. The recent spike in popularity for cannabis and cannabinoid-rich products is a reflection of this movement- one that has led many to want to cultivate a more intentional relationship with this healing herb.

In the last several years there’s been a big spotlight placed on cannabis. It seems as though this medicinal plant is finally getting the recognition it deserves for the many health benefits it offers.  As cannabinoids become one of the most sought-after natural products on the market, we see consumers eager to ask more questions on a personal quest to learn as much as they can about the topic. For this reason, a helpful guide to cannabinoids can assist in educating and clarifying some of the finer points relating to the science of, and the synergy between cannabinoids, as well as some broader questions pertaining to its current place in modern society.

Let’s get started…

The Science-

Cannabinoids affect many important functions in the endocannabinoid system in our bodies. CBD for instance has pain relieving, antioxidant, anti-inflammatory and anti-nausea effects, while CBN has been shown to act as a sedative, and is helpful in managing anxiety, while CBC has antibiotic, antifungal, anti-inflammatory properties and helps relieve pain and so on. There has been extensive research regarding the internal interplay when cannabinoids, flavonoids, terpenes and fatty acids all work in concert to abate symptoms of pain, inflammation, depression, anxiety, fungal, bacterial infections and more.

Each cannabinoid has a different and beneficial effect in our body. Here are some of the more common ones along with their specific function:

  • Cannabinol (CBN): sedative, antibiotic, anticonvulsant, and anti-inflammatory.
  • Cannabidiol (CBD): anticonvulsant, antioxidant, reduces anxiety, treats psychotic disorders, relieves pain, reduces inflammation, and relieves spasms
  • Tetrahydrocannabinol (THC) ; antioxidant, anti-inflammatory, induces a euphoric high, relieves pain
  • Cannabigerol (CBG): antibiotic, anti-fungal, anti-inflammatory, and relieves pain
  • Cannabichromene (CBC): antibiotic, anti-fungal, anti-inflammatory, and relieves pain.
  • Tetrahydrocannabivarin (THCV): induces a euphoric high and relieves anxiety.

 

But how does it work?…

Cannabinoids have a profound and positive impact on the body’s own receptor system. Scientists are still trying to figure out exactly how those chemical compounds interact with each other and within the human body. Although there is increasing evidence that there may be more types, today we know about two receptors: CB1 and CB2. These receptors are distributed on the surface of many different types of cells in the body. CB1 receptors are found primarily on neurons in the brain- like in the amygdala, which influence emotions such as fear and anxiety. A high density of CB1 receptors are also found in the hippocampus, those influence the learning and absorption of new information as well as memory integration. As for the second class of receptor, CB2, those are more abundant in the central nervous system and in the peripheral tissues and organs, particularly in the immune system cells and thus are thought to act in a primarily protective role.

-The Synergy-

Medicinal plants like cannabis contain a wide variety of potentially beneficial compounds. Choosing between full-spectrum and isolate-type products is an important choice when deciding what products to start using. In full-spectrum phytocannabinoid products, the “whole-plant” is used and nothing is held back or left out. That is because whole-plant or FULL-SPECTRUM products are known to include not just CBD but trace amounts of different cannabinoids which introduce various potential benefits that can address a wide variety of ailments both on their own and in conjunction with one another. An isolate is of course effective but studies show that full spectrum CBD is capable of offering greater levels of relief. That is because full-spectrum oils include a wide range of cannabinoids which work synergistically. People seem to respond better to products which contain multiple cannabinoids opposed to single cannabinoids in isolation. And, unsurprisingly, this finding is in line with how cannabinoids are found in nature as opposed to being produced synthetically in a lab. As we can see, when certain isolated components are combined together, they produce a greater more tangible benefit to the user—and this interaction actually has a name, it’s known as the entourage effect.

The term entourage effect was first used decades ago by two Israeli scientists Shimon Ben-Shabat and Raphael Mechoulam upon realizing that cannabinoids found in the cannabis plant actually work in a similar way as the body’s own endocannabinoid system. Each separate cannabinoid has a different and beneficial effect in our body. While researchers agree that more studies are needed to understand the entourage effect, many can attest that the heightened efficacy when compounds operate together is real and not imagined.  Not only can this be seen between certain cannabinoids but also in how terpenes and flavonoids work synergistically increasing the cerebral blood flow while impacting the blood-brain barrier.  As research continues, our knowledge will collectively broaden. The good news is that the field is wide open for greater exploration and development.

Society-

As the popularity of hemp-derived products continue to grow, so has its acceptance across many of the states in America. Just this summer, a major step was taken to pass legislation that would legalize hemp as part of the 2018 Farm Bill. Many agree we seem to be moving in the right direction amidst the changing political landscape of today although, “Is it legal?” is still a common question. Many wish the answers were more straightforward but the reason for the current murkiness is because there are different laws in different states, as well as different laws at the state and also federal levels.

CBD oil that is hemp-derived and consists of no illegal amounts of THC is legal in most states. As of this year, there are states where the recreational and medicinal use of cannabis is also completely legal. They are Colorado, Maine, Massachusetts, Nevada, Oregon, Washington and Alaska. That means if you live in these states, you are free to use CBD and other products without a prescription. Unfortunately, it seems as though laws are constantly in flux, which adds to the legal confusion. Hopefully, there will be more clarity and consistency coming from state and federal authorities sometime in the near future.

So the short answer to, “Is it legal?’ is, there is no short answer. You must check the local law in the state where you live- and stay up on any and all changes. If you live in a state where the recreational use of cannabis is legal, you can use CBD that comes from marijuana or hemp without issue (with the exception of California and provided you are at least 21 years of age). If you live in a state where medical cannabis is legal, and you have a prescription, you are also in the clear. For everyone else in the country, the laws surrounding CBD are stuck in a temporary gray zone. Eventually, many believe that all the states in the country, even the most culturally conservative ones will submit to peoples’ demands and the growing scientific research and legalize cannabis use for medical purposes- once and for all.

Categories
Feature Story Gonorrhea In the News Latest News Marketing Medical Sexually Transmitted Infections Top Stories

Earth Science Tech LTD (ETST) Promotes Women’s Health with Strategically Branded Self-sampling Kit

DORAL, Florida, Oct. 09, 2018 (GLOBE NEWSWIRE) —

Earth Science Tech LTD (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today details its branding strategy for Hygee™, a medical device designed for the detection of sexually transmitted infections (STIs) in women. With plans to market Hygee™ on five continents, ETST is deploying a striking graphic identity that will speak directly to women.

“From the name of the device to specifics of the logo, our branding strategy reflects the personal yet crucial nature of the Hygee™ self-sampling kit. We wanted to make the brand memorable, yet simple enough to promote its ease-of-use,” states Nickolas S. Tabraue, president, director and chairman of ETST. “Hygee™ is associated with peace of mind, protection, security, health and wellness.”A play on the Greek word for “hygiene,” the name Hygee™ integrates intimacy, confidentiality and discretion. Hygee™ looks like – and is worn like – a standard panty liner. Aptly named, the device allows a woman to discreetly take her own sample for testing to detect STIs, starting with chlamydia.

The positioning of “Personal feminine health test” explains the purpose of the product. Set under the logo, it gives the target market the context needed to better understand the brand.

The tagline, “Accurate, Simple and Discreet,” reflects the personal nature of the product.

ETST CEO and Chief Science Officer Dr. Michel Aubé said, “Hygee™ is designed to preserve women’s health. Our goal is to act upstream to give women the control and the information they need to avoid severe health complications from STI.”

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3330935c-ad09-415b-b662-94d805e17ceb

The Market

While STIs are a serious problem worldwide, the rates of infection across the USA have increased for the third consecutive year, according to the Centers for Disease Control and Prevention. The market for Hygee™ is considerable, as no one uses this technology to perform the 100 million tests for Chlamydia trachomatis done around the world each year. ETST believes Hygee™ will be an ideal tool for high throughput screening of individuals who want to know if they are infected with STIs like chlamydia and gonorrhea. It is accepted that young women are also at higher risk, and this is why ETST will market Hygee™ to target that demographic.

“The best way to fight STIs is prevention, and the only way for women to avoid the dangerous results of untreated STI is early treatment. This means that women need to know if they are infected. We believe that Hygee™ will be the best tool to provide that information. ETST will target specific populations of women globally to better counter the STI epidemic,” said Dr. Aubé.

About Earth Science Tech LTD (ETST)

Earth Science Tech LTD (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market.. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.

To learn more, please visit: www.earthsciencetech.com

Categories
Cannabis Oils Cannabis Plant Hemp Oil In the News Industrial Hemp Latest News Marketing Press Releases Top Stories

Earth Science Tech Announces Highly Anticipated New Revamp Industrial Hemp Products Launch Date & Forecasts Highest Grossing Month

Doral, FL, February 8, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces launch date on the Company’s highly anticipated new revamp industrial hemp products and forecasts highest grossing month.

Monday, February 12, 2018 is the official launch dat foe the Company’s highly anticipated High Grade Full Spectrum Cannabinoids new revamp products and marketing strategy, announced early December 2017.

High Grade Full Spectrum Cannabinoids is composed of Netherland CO2 supercritical extracted organically grown unfiltered industrial hemp. The Company originally was planning on using American industrial hemp but, was able to secure a reliable high quality source in Europe to continue offering European industrial hemp causing the slight delay in launching. ETST will be one of the first companies to market it’s industrial hemp product as a Cannabinoid Complex, disclosing the mgs of each Cannabinoid, (CBD, CBDV, CBG, CBC, CBN, & CBDA). Cannabinoid complex is naturally occurring in the 7% CBD industrial hemp plant used and is rich in Terpenes, and Saponins as well. Mixed, bottled,  and packaged in the U.S. at a CGMP facility, the Company’s High Grade Full Spectrum Cannabinoids offer the highest consistent quality that current end users trust and carry forward. Preorders are being accepted online.

Since the announcement last year on our new revamp, Mr. Checkout distributor launched last week, and new veteran Chef Sales Officer, (CSO), the exponential demand has the Company forecast the highest revenue month to date. The Company currently has new chain stores, clinics, and health shops eagerly waiting for the launch to place their orders.

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “the feedback alone  the visual have been positively overwhelming. Thanks to our new CSO our sales effective growing sales team along with our CLO’s product education guidance we look have a grand presence domestically and truly stand out in the CBD industry. I would like to update our stakeholders that our audit looks to be done by the end of next week followed by the Tier II Reg A+ submission and plan on announcing completion as well as other materials progress ”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Categories
Cannabis Oils Hemp Oil In the News Industrial Hemp Latest News Marketing Press Releases

Earth Science Tech Announces Launch Dates & Forecasts for Highly-Anticipated, Revamped Industrial Hemp Products

Doral, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announced launch date for the Company’s highly-anticipated, revamped industrial hemp Cannabidiol (CBD) products, which lead to forecast updates reflecting to a record-high monthly revenue.

February 13, 2018 is the official launch date for the Company’s highly anticipated High Grade Full Spectrum Cannabinoids product, and corresponding marketing strategy, announced early December 2017.

High Grade Full Spectrum Cannabinoids is composed of European CO2, supercritical extracted, organically grown, and unfiltered industrial hemp. The Company was originally planning on using American industrial hemp but was able to secure a reliable high-quality source in Europe to continue offering European industrial hemp, which led to slight delays from the original launch time frame. ETST will be one of the first companies to market its industrial hemp product as a Cannabinoid Complex instead of CBD, disclosing the milligrams (mg) of each Cannabinoid (CBD, CBDV, CBG, CBC, CBN, & CBDA). Cannabinoid complex is naturally occurring in the industrial hemp plant used, and is rich in Terpenes, and Saponins. Mixed, bottled, and packaged in the U.S. at a CGMP facility, the Company’s High Grade Full Spectrum Cannabinoids offer the highest therapeutic quality that current end-users trust and carry forward. Preorders are currently being accepted online.

Since last year’s announcement on product and marketing strategy revamp, Mr. Checkout distributor launched last week, and new veteran Chef Sales Officer, (CSO), the exponential demand increase has led the Company to revise forecasts to reflect what is anticipated to be the highest revenue month to date. The Company has new chain stores, clinics, and health shops eagerly waiting for the official launch to place their initial orders.

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “Between appointing a new Chief Sales Officer, launching revamped industrial hemp products with fresh branding and marketing strategies, and our new distributor Mr. Checkout, we are on track for a record-setting revenue month. We’ve made clear that we intend to make 2018 our breakout year, and we are laying a strong foundation in this first quarter. We will continue to provide updates on our material events as we can.”

“While much of the up-listing and Reg A+ offering processes are out of our hands, we want to reassure our shareholders that we have worked hard to prepare the required paperwork for our audit and offering filings. We are prioritizing transparency and creating lasting value for our stakeholders and are committed to up-listing to the QB tier of the OTC Markets this year. We will provide updates as progress is made.”

Categories
In the News Latest News Marketing Press Releases

Earth Science Tech Appoints New Board Member, Mr. Avi Levy, Esq., to Develop Canadian Market

Doral, FL, January 09, 2018 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or, the “Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device R&D, is pleased to announce the appointment of Mr. Avi Levy, Esq. as the company’s legal consultant for Canadian activities.

With Mr. Levy’s expertise as a highly-regarded lawyer, the company plans to expand its business in Canada. Levy has been practicing law for over twenty-two years and has been involved in both criminal and civil law since the beginning of his practice. He started his career at one of the biggest law firms in Canada, where he worked in tax and estate law, dealing mostly with regulatory issues, and as a prosecutor. He went on to advise and act as general counsel to some of the biggest internet companies, in addition to top athletes and celebrities in the United States. Most recently, Mr. Levy established himself as an expert in the medical marijuana industry, representing some of Canada’s largest clinics and counseling them on regulatory and legal issues.

Mr. Levy will help the company apply for licenses to import its CBD-rich hemp oil into Canada, where it will be transformed and exported in bulk as raw hemp oil, or in individual ready-to-consume bottles. CBD-rich hemp oil is growing in popularity around the world, and ETST hopes to soon begin exporting from its Canadian facilities to various different countries. The company will also profit from the new Canadian market that is opening for cannabis edible products.

“We will be well prepared for that new market. We will manufacture and start to distribute our 3 new CBD-based nutraceutical products in USA in 2018 and in 2019, following our application to get a license to work with schedule II controlled substances,” said Mr. Levy, “We will develop new products with a mix of CBD and THC-rich cannabis oil. In Canada there will be a huge amount of production of dried cannabis herb, and we will profit from purchasing and transforming the excess stock these companies create.”

“We are very excited to welcome Mr. Avi Levy, Esq. to our board of directors,” said CEO & CSO, Michel Aubé, “He brings with him decades of experience in advising companies and individuals in rapid-growth environments, has personal connections to top brands and celebrities, and has worked directly with the cannabis industry. We can’t wait to explore the synergies we have with him, and watch our Canadian prospects grow.”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrate that we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.Earthsciencepharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.Cannabisthera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.kannabidioidinc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

 

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118